„We were awarded with the European Frost & Sullivan Technology Innovation Award for our unique smart polymer technology“, says Christoph Schäfer, CEO of CIS Pharma.
“Our proprietary polymers are based on amino-acids exhibiting superior biocompatibility, resolving issues with conventional medical-grade polymers for bio-medical use. The polymers can be loaded with drugs for target-specific release, improving the quality of patient care and addressing unmet medical needs. With its intelligent properties, the poylmers are finding strong prospects in various applications.”
„The most noticeable factor is the control over chemical and physical properties“, explains Mukherjee of Frost and Sullivan. „With such intelligent functionality, the polymer platform opens a wide range of applications for drug delivery, bio-medical implants and replacements.“